Group 1: Core Technology and Development - The "Beijing Brain No. 1" intelligent brain-machine interface system has completed the first international human implantations of a flexible, high-throughput, semi-invasive wireless brain-machine system, entering the clinical validation phase with 5 patients implanted [1][4] - The system features over 128 channels for signal collection, achieving the highest signal throughput among similar products globally, with advanced signal acquisition precision and processing performance [2][3] - The system allows patients with spinal cord injuries, strokes, and ALS to regain motor and speech functions through neural decoding algorithms that convert brain signals into control commands for external devices [3][4] Group 2: Clinical Applications and Patient Outcomes - The first patient implanted with the "Beijing Brain No. 1" system can control a robotic arm and computer cursor using thought, showing significant recovery in upper limb functions [3][4] - A patient with ALS has successfully decoded nearly 100 common phrases post-implantation, demonstrating the system's potential to restore communication abilities [4] - Another patient with spinal cord injury has shown improvements in lower limb muscle strength and bowel function after receiving the system in conjunction with spinal cord stimulation [4] Group 3: Industry Context and Future Prospects - The Beijing Brain Science and Brain-like Research Institute has produced significant results in brain-machine interfaces and gene therapy, with 14 clinical research approvals for various neurological conditions [6][7] - The medical and health industry in Beijing reached a scale of 1.06 trillion yuan in 2023, with a year-on-year growth of 8.7%, reflecting the advancements in brain-machine interface technology [7]